Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Clinical trial NCT02945280 · TERMINATED

Trial details

NCT number: NCT02945280
Sponsor: Intermountain Health Care, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Deep Venous Thrombosis Upper Extremity Deep Venous Thrombosis Thrombus Venous Thromboembolism Deep Vein Thrombosis

Start date: 2017-02-22
Primary completion: 2021-11-11
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.